143 related articles for article (PubMed ID: 36948238)
1. Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors.
Vogg N; Müller T; Floren A; Dandekar T; Riester A; Dischinger U; Kurlbaum M; Kroiss M; Fassnacht M
Clin Chim Acta; 2023 Mar; 543():117301. PubMed ID: 36948238
[TBL] [Abstract][Full Text] [Related]
2. High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders.
Hines JM; Bancos I; Bancos C; Singh RD; Avula AV; Young WF; Grebe SK; Singh RJ
Clin Chem; 2017 Dec; 63(12):1824-1835. PubMed ID: 28814383
[TBL] [Abstract][Full Text] [Related]
3. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
[TBL] [Abstract][Full Text] [Related]
4. Targeted metabolic profiling of urinary steroids with a focus on analytical accuracy and sample stability.
Vogg N; Müller T; Floren A; Dandekar T; Scherf-Clavel O; Fassnacht M; Kroiss M; Kurlbaum M
J Mass Spectrom Adv Clin Lab; 2022 Aug; 25():44-52. PubMed ID: 35910411
[TBL] [Abstract][Full Text] [Related]
5. Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.
Velikanova LI; Shafigullina ZR; Lisitsin AA; Vorokhobina NV; Grigoryan K; Kukhianidze EA; Strelnikova EG; Krivokhizhina NS; Krasnov LM; Fedorov EA; Sablin IV; Moskvin AL; Bessonova EA
Horm Cancer; 2016 Dec; 7(5-6):327-335. PubMed ID: 27370636
[TBL] [Abstract][Full Text] [Related]
6. A 13-Steroid Serum Panel Based on LC-MS/MS: Use in Detection of Adrenocortical Carcinoma.
Taylor DR; Ghataore L; Couchman L; Vincent RP; Whitelaw B; Lewis D; Diaz-Cano S; Galata G; Schulte KM; Aylwin S; Taylor NF
Clin Chem; 2017 Dec; 63(12):1836-1846. PubMed ID: 28904054
[TBL] [Abstract][Full Text] [Related]
7. Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma.
Schweitzer S; Kunz M; Kurlbaum M; Vey J; Kendl S; Deutschbein T; Hahner S; Fassnacht M; Dandekar T; Kroiss M
Eur J Endocrinol; 2019 Feb; 180(2):117-125. PubMed ID: 30481155
[TBL] [Abstract][Full Text] [Related]
8. Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours.
Tiu SC; Chan AO; Taylor NF; Lee CY; Loung PY; Choi CH; Shek CC
Hong Kong Med J; 2009 Dec; 15(6):463-70. PubMed ID: 19966352
[TBL] [Abstract][Full Text] [Related]
9. Serum steroid profiling by mass spectrometry in adrenocortical tumors: diagnostic implications.
Fanelli F; Di Dalmazi G
Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):160-165. PubMed ID: 30893084
[TBL] [Abstract][Full Text] [Related]
10. Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma.
Chortis V; Bancos I; Nijman T; Gilligan LC; Taylor AE; Ronchi CL; O'Reilly MW; Schreiner J; Asia M; Riester A; Perotti P; Libé R; Quinkler M; Canu L; Paiva I; Bugalho MJ; Kastelan D; Dennedy MC; Sherlock M; Ambroziak U; Vassiliadi D; Bertherat J; Beuschlein F; Fassnacht M; Deeks JJ; Biehl M; Arlt W
J Clin Endocrinol Metab; 2020 Mar; 105(3):e307-18. PubMed ID: 31665449
[TBL] [Abstract][Full Text] [Related]
11. Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma.
Suzuki S; Minamidate T; Shiga A; Ruike Y; Ishiwata K; Naito K; Ishida A; Deguchi H; Fujimoto M; Koide H; Tatsuno I; Ikeda JI; Yamazaki Y; Sasano H; Yokote K
BMC Endocr Disord; 2020 Nov; 20(1):173. PubMed ID: 33228607
[TBL] [Abstract][Full Text] [Related]
12. Steroid Profiling by LC-MS/MS in Nonsecreting and Subclinical Cortisol-Secreting Adrenocortical Adenomas.
Di Dalmazi G; Fanelli F; Mezzullo M; Casadio E; Rinaldi E; Garelli S; Giampalma E; Mosconi C; Golfieri R; Vicennati V; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2015 Sep; 100(9):3529-38. PubMed ID: 26161451
[TBL] [Abstract][Full Text] [Related]
13. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of a malignant adrenal mass: the role of urinary steroid metabolite profiling.
Bancos I; Arlt W
Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):200-207. PubMed ID: 28234802
[TBL] [Abstract][Full Text] [Related]
15. Steroid profiling in adrenal disease.
Mu D; Sun D; Qian X; Ma X; Qiu L; Cheng X; Yu S
Clin Chim Acta; 2024 Jan; 553():117749. PubMed ID: 38169194
[TBL] [Abstract][Full Text] [Related]
16. Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review.
Araujo-Castro M; Valderrábano P; Escobar-Morreale HF; Hanzu FA; Casals G
Endocrine; 2021 Apr; 72(1):40-48. PubMed ID: 33219921
[TBL] [Abstract][Full Text] [Related]
17. An LC-MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism.
Peitzsch M; Dekkers T; Haase M; Sweep FC; Quack I; Antoch G; Siegert G; Lenders JW; Deinum J; Willenberg HS; Eisenhofer G
J Steroid Biochem Mol Biol; 2015 Jan; 145():75-84. PubMed ID: 25312486
[TBL] [Abstract][Full Text] [Related]
18. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
19. A Diagnostic Approach to Adrenocortical Tumors.
Hodgson A; Pakbaz S; Mete O
Surg Pathol Clin; 2019 Dec; 12(4):967-995. PubMed ID: 31672302
[TBL] [Abstract][Full Text] [Related]
20. Urinary steroid profile in adrenocortical tumors.
Kikuchi E; Yanaihara H; Nakashima J; Homma K; Ohigashi T; Asakura H; Tachibana M; Shibata H; Saruta T; Murai M
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():194s-197s. PubMed ID: 10915023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
